Min Liao
Directeur/Membre du Conseil chez Wuhan Canvest Biotechnology Co., Ltd.
Profil
Min Liao is a Director at Wuhan Canvest Biotechnology Co., Ltd.
since 2019.
Previously, Mr. Liao worked as a Director at YingTong Telecommunication Co., Ltd.
Mr. Liao holds an MBA from City University of Macau.
Postes actifs de Min Liao
| Sociétés | Poste | Début |
|---|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
 Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Directeur/Membre du Conseil | 17/09/2019 |
Anciens postes connus de Min Liao
| Sociétés | Poste | Fin |
|---|---|---|
| YINGTONG TELECOMMUNICATION CO.,LTD. | Directeur/Membre du Conseil | 09/01/2020 |
Formation de Min Liao
| City University of Macau | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| YINGTONG TELECOMMUNICATION CO.,LTD. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Health Technology |
